Navigation Links
CEO's Letter to Shareholders of Imaging Diagnostic Systems, Inc.
Date:8/5/2008

izing the CTLM(R) in late 2002, we sold our first CTLM(R) system in January 2003. Since that sale, we sold 12 additional units. There are CTLM(R) systems sold or in clinical collaboration programs currently in China, Italy, Poland, Czech Republic, United Arab Emirates, and Malaysia. Our end users and clinical collaboration partners worldwide have completed more than 13,000 clinical scans. We have deposits for the purchase of CTLM(R) systems from our distributors in Hong Kong and Turkey; and our Director of Global Marketing is working with our distributors to bring their earnest leads to sale before the end of the year. We anticipate the sale of eight CTLM(R) systems before the end of the year in China, Italy, and the United Arab Emirates.

Our stock price has also faced challenges over the past several years as the Company evolved to establish itself on the market. IDSI is an equity-funded Company. Since inception, substantially all of our necessary funding came from the proceeds of the sale of common stock, convertible preferred stock and convertible debentures. The convertible securities were all converted into common stock. In essence, our common stock is our currency and since January 2001 we have used a series of private equity credit agreements with Charlton Avenue, LLC, an institutional investor, to raise the capital necessary to fund the Company's operations. The use of private equity credit agreements is dilutive as the investor sells our shares into the market.

Cost cutting initiatives and staff reductions were initiated in April by the time I was appointed Interim CEO and Chairman of the Board. I met with Executive Management and we made the decision to terminate our lease pursuant to the six-month notice provision and to lease a smaller facility. Our current facility is 24,000 sq/ft with a base rent of $24,000 per month plus insurance, taxes and maintenance, which we estimate to be $9,440 per month for a total monthly cost of $33,440. Our ne
'/>"/>

SOURCE Imaging Diagnostic Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
2. Three CEOs and University President Named Winners of Greater Baltimore Committees 2008 Baltimore Region Bioscience Awards
3. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
4. Survey Sees Mass. CEOs as Bullish on Own Businesses
5. Alfacell Receives NASDAQ Delisting Letter
6. Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd.
7. Eisai Receives Action Letter on Fospropofol Disodium Injection for Sedation in Diagnostic or Therapeutic Procedures
8. Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule
9. Spherix Receives NASDAQ Bid Price Deficiency Letter
10. Favrille Announces Receipt of Nasdaq Letters
11. Telik Announces Publication of Diabetes Research in Bioorganic & Medicinal Chemistry Letters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 2015 According to a new ... Modeling, PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract ... Trial), by End Users - Global Forecast to 2020", ... reach USD 2,107.99 million by 2020 from USD 1,034.93 ... Browse more than 75 ...
(Date:7/30/2015)...  With over 60,000 customers across the globe, ISN improves the efficiency and effectiveness ... more than 60,000 safe and reliable contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers In ... Headquartered in Dallas, TX , ISN has additional ...
(Date:7/30/2015)... ... 2015 , ... As part of its 2015 growth plan and as a follow up to ... business units, Whitehouse Laboratories is pleased to announce that it has begun construction on a ... Excellence and will be strictly dedicated to basic USP 51, USP 61, and USP 62 ...
(Date:7/29/2015)... , July 30, 2015 According to ... - Growth, Trends & Forecasts (2015-2020), , published by Mordor ... 30.25 billion by the end of 2020, with ... for more than 40% of the global market size. The ... a CAGR of 13.7% during the period of (2015-2020). ...
Breaking Biology Technology:Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3Whitehouse Labs Formally Announces Plans to Open a Microbiological Laboratory 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 3
... 27 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ... Chief Executive Officer, will present at the 5th Annual ... September 28, 2010, at 10:30 a.m. Eastern Time. ... presentations will be accessible by visiting the Oncothyreon website ...
... Experience in STEMI Patients.... -- WASHINGTON, September 24, 2010 ... ... ... first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var ...
... GeneLink BioSciences, Inc. (OTC Bulletin Board: GNLK, ... www.helixlife.com ), a private label distribution partnership serving the ... CEO, stated, "HelixLife gives GeneLink reach into new areas ... have not been available to us.  The HelixLife team ...
Cached Biology Technology:InspireMD Presents 2 Years Clinical Outcome of MGuard Multicenter Experience in STEMI Patients. The New Superb Clinical Results Were celebrated at InspireMD's TCT Satellite Symposium in Washington DC., Today. 2InspireMD Presents 2 Years Clinical Outcome of MGuard Multicenter Experience in STEMI Patients. The New Superb Clinical Results Were celebrated at InspireMD's TCT Satellite Symposium in Washington DC., Today. 3InspireMD Presents 2 Years Clinical Outcome of MGuard Multicenter Experience in STEMI Patients. The New Superb Clinical Results Were celebrated at InspireMD's TCT Satellite Symposium in Washington DC., Today. 4InspireMD Presents 2 Years Clinical Outcome of MGuard Multicenter Experience in STEMI Patients. The New Superb Clinical Results Were celebrated at InspireMD's TCT Satellite Symposium in Washington DC., Today. 5InspireMD Presents 2 Years Clinical Outcome of MGuard Multicenter Experience in STEMI Patients. The New Superb Clinical Results Were celebrated at InspireMD's TCT Satellite Symposium in Washington DC., Today. 6InspireMD Presents 2 Years Clinical Outcome of MGuard Multicenter Experience in STEMI Patients. The New Superb Clinical Results Were celebrated at InspireMD's TCT Satellite Symposium in Washington DC., Today. 7GeneLink Announces HelixLife Private Label Distribution Agreement 2
(Date:7/21/2015)... July 21, 2015 Passwords have proven ... in the recent U.S. Office of Personnel Management ... the infosec conundrum, but developers and end-users are ... address this dilemma, Biometrics-as-a-Service provider HYPR Corp. announced ... SDK for third party integration. ...
(Date:7/9/2015)... , July 07, 2015 ... the addition of the "Biometrics for Banking; ... 2015-2020" report to their offering. ... contributor to this growth and the forecast is ... in revenue for companies involved in delivering biometric ...
(Date:7/8/2015)... 8, 2015  Trovagene, Inc. (NASDAQ: TROV ... announced the launch of a study that aims ... Monitoring℠ (PCM) technology for predicting response to treatment ... combination of the novel immunotherapy agents Yervoy® (ipilumumab), ... inhibitor. The 50-patient study will be led by ...
Breaking Biology News(10 mins):HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... . . Michael J. Ryan, Ph.D., a scientist at The ... a new horned dinosaur, Medusaceratops lokii . Approximately ... newly identified plant-eating dinosaur lived nearly 78 million years ago ... Its identification marks the discovery of a new genus ...
... Ardipithecus ramidus a purported human ancestor that was ... coming under fire from scientists who say there is scant ... at the African site where the creature lived 4.4 million ... savanna habitats," says University of Utah geochemist Thure Cerling, lead ...
... host a round-the-clock, robotically choreographed hunt for carbon-hungry materials. ... diverse team of scientists whose goal is to quickly ... a power plant,s exhaust, before it leaves the smokestack ... a recently discovered class of materials called metal-organic frameworks ...
Cached Biology News:Cleveland Museum of Natural History scientist announces new horned dinosaur 2Cleveland Museum of Natural History scientist announces new horned dinosaur 3Out of the woods for 'Ardi' 2Out of the woods for 'Ardi' 3Out of the woods for 'Ardi' 4The search for improved carbon sponges picks up speed 2The search for improved carbon sponges picks up speed 3
... For the professional, student, or faculty researcher, ... will accelerate your research and improve the quality ... data is the edge that researchers using LI-COR ... 10 years. The 4300 System is a third ...
This free-standing work station safely ventilates fumes upwards, away from the work surface. Optional Exhaust Purification System features bonded charcoal filters that remove organic chemical vapors ...
... biocompatibility testing at various temperatures, this ... through a clean heating unit to ... to 140F. Transparent panels allow full ... easy access to the work area. ...
... Tracker Intracellular Localization Kit with TransIT-siQUEST ... approach to directly label and deliver ... efficient yet non-destructive manner, for in ... functional inhibition of target gene expression ...
Biology Products: